SeaStar Medical Holding Corp — Form 10-Q
Filed August 12, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 5/100
What the filing says
The filing contains only boilerplate SOX 302 and 906 certifications signed by CEO Eric Schlorff and CFO Michael Messinger on August 12, 2026, for the Q2 2026 10-Q. Both officers certify the report complies with disclosure rules and fairly presents financial condition. No material transactions, guidance changes, financing events, or operational developments are disclosed in the provided exhibit text.
Why this rating
Routine certification exhibits contain no business substance—standard periodic compliance filings. No material events, transactions, or disclosures present.
See more from August 12, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.